SEC Filing Summary: Bellevue Life Sciences Acquisition Corp.
Business Context and Reporting Period
This Form 8-K was filed by Bellevue Life Sciences Acquisition Corp. (BLAC) on August 16, 2024, reporting an event that occurred on August 13, 2024. The registrant is a Special Purpose Acquisition Company (SPAC) incorporated in Delaware, with securities trading on The Nasdaq Stock Market LLC under the symbols BLACU, BLAC, BLACW, and BLACR.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or margin data. The only specific financial metric disclosed is a cash deposit of $50,000 made into the company's trust account.
Material Changes
The primary material event reported is the extension of the deadline by which the Company must consummate a business combination. To facilitate this extension, $50,000 was deposited into the trust account on August 13, 2024.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the implication that the company has not yet completed a business combination and required an extension of its timeline. No unusual items or contingencies are detailed in this specific report.
Investor Verification Checklist
- Verify the new deadline date for consummating a business combination following this extension.
- Confirm the total balance of the trust account after the $50,000 deposit.
- Review the terms of the extension, including any potential dilution or additional funding requirements for future extensions.
- Check for any concurrent announcements regarding potential target companies or merger negotiations.